bromodeoxyuridine has been researched along with Anaplastic Oligodendroglioma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, AK; Lau, KM; Li, KK; Mao, Y; Ng, HK; Pang, JC; Poon, WS; Shi, Z; Wang, Y; Yang, L; Zhou, L | 1 |
Battermann, JJ; Jansen, GH; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
Dawson, G; Kernes, SM | 1 |
Hayakawa, T; Mogami, H; Yoshimine, T | 1 |
Hoshino, T; Nagai, M; Sano, K | 1 |
Hoshino, T | 1 |
Mundinger, F | 1 |
7 other study(ies) available for bromodeoxyuridine and Anaplastic Oligodendroglioma
Article | Year |
---|---|
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.
Topics: Adult; Aged; Azacitidine; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cellular Apoptosis Susceptibility Protein; Child; Cohort Studies; Collagen; Decitabine; Down-Regulation; Drug Combinations; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Kaplan-Meier Estimate; Laminin; Male; MicroRNAs; Middle Aged; Oligodendroglioma; Proteoglycans | 2013 |
S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Topics: Aneuploidy; Antimetabolites; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Diploidy; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Meningioma; Oligodendroglioma; Ploidies; S Phase | 1997 |
Mechanism of action of hydrocortisone potentiation of sulfogalactosylceramide synthesis in mouse oligodendroglioma clonal cell lines.
Topics: Bromodeoxyuridine; Cell Line; Cerebrosides; Clone Cells; Cortisone; Dexamethasone; Estradiol; Galactosylceramides; Glycosaminoglycans; Hydrocortisone; Hydrolases; Kinetics; Lysosomes; Oligodendroglioma; Sulfates | 1979 |
[Factors affecting the prognosis of brain tumors].
Topics: Age Factors; Antibodies, Monoclonal; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Epidermal Growth Factor; ErbB Receptors; Glioblastoma; Humans; Meningioma; Oligodendroglioma; Oncogenes; Prognosis | 1988 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; Follow-Up Studies; Glioma; Humans; Meningioma; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Thymidine | 1968 |
[Treatment of malignant brain tumors by BAR therapy].
Topics: Adolescent; Adult; Arteries; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Meningioma; Middle Aged; Neoplasm Metastasis; Oligodendroglioma; Papilloma | 1968 |
[Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Ependymoma; Glioblastoma; Humans; Iridium; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Rats; Thymidine | 1972 |